Federated Hermes’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Federated Hermes’s Portfolio MRNS Stock Details MRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,286	Closed	-$1.22K	–	2234
2024 Q4	$1.22K	Sell	2,286 -1,454	-39%	-$1.01K	﹤0.01%	2007
2024 Q3	$6.58K	Sell	3,740 -2,086	-36%	-$2.91K	﹤0.01%	1835
2024 Q2	$6.82K	Buy	+5,826	New	+$14.6K	﹤0.01%	1811
2023 Q4	–	Sell	-50	Closed	-$403	–	2241
2023 Q3	$403	Sell	50 -81,914	-100%	-$681K	﹤0.01%	2050
2023 Q2	$890K	Buy	+81,964	New	+$702K	﹤0.01%	1174

Federated Hermes's MRNS Position: Q1 2025 in Review

Federated Hermes sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2025, closing a stake of 2,286 shares — an estimated $1.22K sold.

Federated Hermes first reported a position in MRNS in Q2 2023 and held it in 5 quarters. The position peaked at $890K in Q2 2023. 0 funds tracked by Wall St. Rank hold MRNS as of Q1 2025.

Federated Hermes reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2025 after selling out during the quarter.
Federated Hermes sold 2,286 Marinus Pharmaceuticals, Inc shares in Q1 2025, an estimated $1.22K.
Federated Hermes first reported a position in Marinus Pharmaceuticals, Inc in Q2 2023 and held it in 5 quarters.
Federated Hermes's Marinus Pharmaceuticals, Inc position peaked at $890K in Q2 2023.
0 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2025.

Based on Federated Hermes's 13F filing for Q1 2025, filed 8 May 2025.